EFBA Pharma Journal https://efbapharma.pk/blog/ Evidence-led articles on IV formulations, published research and drug registration in Pakistan from EFBA en-PK © 2026 EFBA Fri, 30 Oct 2026 04:30:00 +0000 https://efbapharma.pk/assets/img/blog/iv-drip-therapy-clinics-pakistan-cover.webp EFBA Pharma Journal https://efbapharma.pk/blog/ IV Drip Therapy in Pakistani Clinics: Evidence, Oversight and Supplier Checks https://efbapharma.pk/blog/iv-drip-therapy-clinics-pakistan/ https://efbapharma.pk/blog/iv-drip-therapy-clinics-pakistan/ Fri, 30 Oct 2026 04:30:00 +0000 Clinical practice No single Pakistani standard covers IV drip services, so clinics are judged under rules on licensing, medicines and advertising. What the 2025 and 2026 record shows, and the file a clinic should be able to produce. Glutathione Injection: Evidence, Safety Signals and How to Check a Product in Pakistan https://efbapharma.pk/blog/glutathione-injection-evidence-safety/ https://efbapharma.pk/blog/glutathione-injection-evidence-safety/ Fri, 30 Oct 2026 04:30:00 +0000 Evidence What the trials of injected glutathione tested, the safety signals regulators have raised, and how to check whether a product on offer in Pakistan is registered with DRAP. DRAP Drug Registration and Import in Pakistan: A Guide for Importers and Distributors https://efbapharma.pk/blog/drap-drug-registration-import-pakistan/ https://efbapharma.pk/blog/drap-drug-registration-import-pakistan/ Fri, 30 Oct 2026 04:30:00 +0000 Regulation The Drug Sale Licence, Form 5-F dossier, Registration Board, import conditions and limits on promotion: how an imported finished drug is registered in Pakistan, with a checklist for importers.